Verastem Inc (NASDAQ: VSTM) open the trading on Wednesday, with a bit cautious approach as it glided -4.09% to $3.28, before settling in for the price of $3.42 at the close. Taking a more long-term approach, VSTM posted a 52-week range of $2.10-$14.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -45.06%. Meanwhile, its Annual Earning per share during the time was 24.76%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 19.22%. This publicly-traded company’s shares outstanding now amounts to $40.24 million, simultaneously with a float of $36.71 million. The organization now has a market capitalization sitting at $131.99 million.
Verastem Inc (VSTM) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Verastem Inc’s current insider ownership accounts for 8.79%, in contrast to 31.99% institutional ownership. According to the most recent insider trade that took place on Oct 07 ’24, this organization’s Chief Financial Officer sold 6 shares at the rate of 2.86, making the entire transaction reach 17 in total value, affecting insider ownership by 47,461. Preceding that transaction, on Sep 20 ’24, Company’s Chief Financial Officer sold 65 for 2.80, making the whole transaction’s value amount to 182. This particular insider is now the holder of 47,495 in total.
Verastem Inc (VSTM) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
Verastem Inc’s EPS increase for this current 12-month fiscal period is 19.22% and is forecasted to reach -2.34 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.74% through the next 5 years, which can be compared against the 24.76% growth it accomplished over the previous five years trading on the market.
Verastem Inc (NASDAQ: VSTM) Trading Performance Indicators
Let’s observe the current performance indicators for Verastem Inc (VSTM). It’s Quick Ratio in the last reported quarter now stands at 3.28. The Stock has managed to achieve an average true range (ATR) of 0.27. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 13.20.
In the same vein, VSTM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.34, a figure that is expected to reach -0.74 in the next quarter, and analysts are predicting that it will be -2.34 at the market close of one year from today.
